Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer is a research paper published in Molecular Therapy (2024). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Research Council of Norway
Grant: 244388
Personalized Immunotherapy: Re-targeting T-cells against cancer
Research Council of Norway
Grant: 337468
KVAL: Tuned CAR-T cells – a novel platform technology
Research Council of Norway
Grant: 326811
KSP: CellFit - T cells fit to fight cancer
Research Council of Norway
Grant: 248902
Adoptive T cell Therapy of Cancer - TCR Biopharma
South-Eastern Norway Regional Health Authority
Grant: WO2017194555
South-Eastern Norway Regional Health Authority
Grant: 2017075
FWCI
2.10
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals